PacBio to Report First Quarter 2026 Financial Results on May 7, 2026
Rhea-AI Summary
PacBio (NASDAQ: PACB) will report first quarter 2026 financial results and host a conference call on Thursday, May 7, 2026 at 4:30 p.m. ET (1:30 p.m. PT). The call will be webcast and available on the company's investor website.
Live listen and replay access are provided via the investor site at https://investor.pacificbiosciences.com/, toll-free dial-in 1-888-349-0136, and international dial-in 1-412-317-0459.
Positive
- None.
Negative
- None.
News Market Reaction – PACB
In the Apr 17 session, PACB gained 3.68%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 27 | Earnings date notice | Neutral | -7.4% | Set date and time for Q4 and full-year 2025 earnings call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings-date scheduling news for PACB was followed by a negative move of about -7.39%, indicating the market has previously treated such notices cautiously.
In the past months, PacBio has combined strategic collaborations and governance changes with regular investor communications. A prior earnings-date announcement on Jan 27, 2026 for Q4 and full-year 2025 results led to a -7.39% move over 24 hours. Against that backdrop, today’s notice setting the Q1 2026 earnings call date continues the cadence of formal updates ahead of detailed financial disclosures.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its first quarter 2026 financial results on Thursday, May 7, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time).
The call will be webcast and may be accessed on PacBio’s website at https://investor.pacificbiosciences.com/.
Date: Thursday, May 7, 2026, at 4:30 p.m. ET (1:30 p.m. PT)
Listen live via internet or replay: https://investor.pacificbiosciences.com/
Toll-free: 1-888-349-0136
International: 1-412-317-0459
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
ir@pacb.com
Media:
pr@pacb.com
